Record 1083 View: Standard | Glossary HistCite Guide |
Author(s): Fuxe K; Dahlstrom A; Hoistad M; Marcellino D; Jansson A; Rivera A; Diaz-Cabiale Z; Jacobsen K; Tinner-Staines B; Hagman B; Leo G; Staines W; Guidolin D; Kehr J; Genedani S; Belluardo N; Agnati LF
Title: From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: Wiring and volume transmission
Source: BRAIN RESEARCH REVIEWS 55 (1): 17-54
Date: 2007 AUG
Document Type: Journal : Article
DOI:
Language: English
Comment:
Address: Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.
Univ Gothenburg, Dept Anat & Cell Biol, S-40530 Gothenburg, Sweden. Univ Malaga, Dept Cell Biol, E-29071 Malaga, Spain. Univ Malaga, Dept Human Physiol, E-29071 Malaga, Spain. Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada. Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy. Univ Padua, Dept Human Anat & Physiol, Padua, Italy. Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden. Univ Palermo, Dept Human Physiol, Palermo, Italy. Reprint: Fuxe, K, Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.
E-mail: Kjell.Fuxe@ki.se
Abstract: After Golgi-Cajal mapped neural circuits, the discovery and mapping of the central monoamine neurons opened up for a new understanding of interneuronal communication by indicating that another form of communication exists. For instance, it was found that dopamine may be released as a prolactin inhibitory factor from the median eminence, indicating an alternative mode of dopamine communication in the brain. Subsequently, the analysis of the locus coeruleus noradrenaline neurons demonstrated a novel type of lower brainstem neuron that monosynaptically and globally innervated the entire CNS. Furthermore, the ascending raphe serotonin neuron systems were found to globally innervate the forebrain with few synapses, and where deficits in serotonergic function appeared to play a major role in depression. We propose that serotonin reuptake inhibitors may produce antidepressant effects through increasing serotonergic neurotrophism in serotonin nerve cells and their targets by transactivation of receptor tyrosine kinases (RTK), involving direct or indirect receptor/RTK interactions. Early chemical neuroanatomical work on the monoamine neurons, involving primitive nervous systems and analysis of peptide neurons, indicated the existence of alternative modes of communication apart from synaptic transmission. In 1986, Agnati and Fuxe introduced the theory of two main types of intercellular communication in the brain: wiring and volume transmission (WT and VT). Synchronization of phasic activity in the morroamine cell clusters through electrotonic coupling and synaptic transmission (WT) enables optimal VT of morroamines in the target regions. Experimental work suggests an integration of WT and VT signals via receptor-receptor interactions, and a new theory of receptor-connexin interactions in electrical and mixed synapses is introduced. Consequently, a new model of brain function must be built, in which communication includes both WT and VT and receptor-receptor interactions in the integration of signals. This will lead to the unified execution of information handling and trophism for optimal brain function and survival. (c) 2007 Elsevier B.V. All rights reserved.
Cited References: AGHAJANIAN GK, 1974, BRAIN RES, V81, P364 AGNATI LE, 2000, PROG BRAIN RES, V125, P303 AGNATI LF, 1979, J NEUROSCI METH, V1, P365 AGNATI LF, 1980, MED BIOL, V58, P182 AGNATI LF, 1982, MED BIOL, V60, P183 AGNATI LF, 1983, NEUROSCI LETT, V35, P179 AGNATI LF, 1986, ACTA PHYSIOL SCAND, V128, P201 AGNATI LF, 1986, PROG BRAIN RES, V68, P291 AGNATI LF, 1991, CLIN J PAIN, V7, PS23 AGNATI LF, 1992, AM SCI, V80, P362 AGNATI LF, 1993, ANAESTH PHARM REV, V2, P101 AGNATI LF, 1994, NEUROREPORT, V6, P9 AGNATI LF, 1995, BRAIN RES, V676, P10 AGNATI LF, 1996, MOL MECH NEURONAL CO, P251 AGNATI LF, 2000, PROG BRAIN RES, V125, P3 AGNATI LF, 2000, VOLUME TRANSMISSION AGNATI LF, 2003, J NEURAL TRANSM-SUPP, P1 AGNATI LF, 2003, PHARMACOL REV, V55, P509 AGNATI LF, 2005, J MOL NEUROSCI, V26, P193 AGNATI LF, 2005, J NEURAL TRANSM, V112, P45 AGNATI LF, 2006, ACTA PHYSIOL, V187, P329 AGNATI LF, 2006, CURR PROTEIN PEPT SC, V7, P3 AGNATI LF, 2006, NEW RES CONSCIOUSNES, P65 AGNATI LF, 2007, J NEURAL TRANSM, V114, P3 AKIL H, 1978, P NATL ACAD SCI USA, V75, P5170 ALBERT PR, 1996, NEUROPSYCHOPHARMACOL, V14, P19 ALHEIM K, 1997, P NATL ACAD SCI USA, V94, P2681 ALVAREZMAUBECIN V, 2000, J NEUROSCI, V20, P4091 AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73 ANDEN NE, 1964, LIFE SCI, V3, P523 ANDEN NE, 1964, NATURE, V202, P1222 ANDEN NE, 1965, AM J ANAT, V116, P329 ANDEN NE, 1965, LIFE SCI, V4, P1275 ANDEN NE, 1966, ACTA PHARMACOL KBH, V24, P263 ANDEN NE, 1966, ACTA PHYSIOL SCAND, V67, P313 ANDEN NE, 1966, EXPERIENTIA, V22, P44 ANDEN NE, 1966, EXPERIENTIA, V22, P842 ANDEN NE, 1968, BRIT J PHARMACOL, V34, P1 ANDEN NE, 1970, EUR J PHARMACOL, V11, P303 ANDEN NE, 1971, J PHARMACOL EXP THER, V179, P236 ANDERSSON K, 1981, EUR J PHARMACOL, V76, P261 ANDERSSON K, 1983, EUR J PHARMACOL, V95, P271 ANDERSSON K, 1984, NEUROSCI LETT, V45, P253 ANDERSSON K, 1985, ACTA PHYSIOL SCAND, V123, P411 ANDERSSON K, 1985, EUR J PHARMACOL, V111, P295 ANDERSSON PB, 1992, NEUROSCIENCE, V48, P169 ANDREWS ZB, 2006, EUR J NEUROSCI, V24, P32 ANTHONY DC, 1997, BRAIN 3, V120, P435 AOKI C, 1992, BRAIN RES BULL, V29, P257 AOKI C, 1992, J NEUROSCI, V12, P781 AOKI C, 1994, J NEUROSCI, V14, P5202 AOKI C, 1998, CEREB CORTEX, V8, P269 ARTIGAS F, 1996, TRENDS NEUROSCI, V19, P378 ASTONJONES G, 1981, J NEUROSCI, V1, P876 ASTONJONES G, 1981, J NEUROSCI, V1, P887 ASTONJONES G, 1991, PROG BRAIN RES, V88, P47 ASTONJONES G, 1992, NEUROSCI LETT, V140, P219 ASTONJONES G, 2005, ANNU REV NEUROSCI, V28, P403 ASTONJONES G, 2005, J COMP NEUROL, V493, P99 ASTONJONES G, 2005, SLEEP MED S1, V6, PS3 ATTWELL D, 1993, NEURON, V11, P401 AZMITIA EC, 1991, J CLIN PSYCHIAT S, V52, P4 AZMITIA EC, 1996, NEUROPSYCHOPHARMACOL, V14, P35 AZMITIA EC, 2001, BRAIN RES BULL, V56, P413 BAKER DA, 2001, MON MOL NEUR 2001 P, P289 BARINAGA M, 1993, SCIENCE, V260, P487 BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441 BAUDE A, 1998, J COMP NEUROL, V402, P181 BEAUDET A, 1978, NEUROSCIENCE, V3, P851 BEHZADI Y, 2005, NEUROIMAGE, V25, P1100 BELLIDO I, 2002, NEUROSCI LETT, V317, P101 BELLUARDO N, 1997, J COMP NEUROL, V379, P226 BENJONATHAN N, 1977, ENDOCRINOLOGY, V100, P452 BENNETT MV, 1978, NEUROSCI RES PROGRAM, V16, P1 BERGHUIS P, 2005, P NATL ACAD SCI USA, V102, P19115 BJELKE B, 1988, NEUROSCI LETT, V93, P139 BJELKE B, 1989, NEUROSCI LETT, V107, P33 BJELKE B, 1993, NEUROREPORT, V5, P265 BJELKE B, 1995, NEUROREPORT, V6, P1005 BJELKE B, 1996, J CHEM NEUROANAT, V12, P37 BLASBERG RG, 1975, J PHARMACOL EXP THER, V195, P73 BLOOM F, 1978, P NATL ACAD SCI USA, V75, P1591 BLOOM F, 1980, NEUROBIOLOGY CEREBRR BONICA JJ, 1990, J PAIN SYMPTOM MANAG, V5, P368 BOUDIN H, 1998, J NEUROSCI, V18, P8473 BOWERS CW, 1994, TRENDS NEUROSCI, V17, P315 BRANTON WD, 1978, NATURE, V274, P70 BRIGHTMAN MW, 1965, AM J ANAT, V117, P193 BRIGHTMAN MW, 2000, CELL MOL NEUROBIOL, V20, P111 BROWNLEES J, 1993, J NEUROCHEM, V60, P793 BRUZZONE R, 2006, CELL TISSUE RES, V326, P239 BUMA P, 1988, CELL TISSUE RES, V252, P107 BUNNEMANN B, 1991, VOLUME TRANSMISSION, P131 BURBACH JPH, 1981, J BIOL CHEM, V256, P2463 BURBACH JPH, 1982, ANN CLIN BIOCHEM, V19, P269 BUTCHER L, 1970, J PHARM PHARMACOL, V22, P313 CABERLOTTO L, 1998, NEUROSCIENCE, V86, P827 CAILLE I, 1996, BRAIN RES, V730, P17 CANALES JJ, 2005, NEUROBIOL LEARN MEM, V83, P93 CANALS M, 2003, J BIOL CHEM, V278, P46741 CARLSSON A, 1962, ACTA PHYSIOL SC S196, V56, P1 CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140 CARLSSON A, 1964, ACTA PHYSIOL SCAND, V60, P112 CARLSSON A, 1968, J PHARM PHARMACOL, V20, P150 CARLSSON A, 1969, BRAIN RES, V12, P456 CARLSSON A, 1969, EUR J PHARMACOL, V5, P357 CARLSSON A, 1988, NEUROPSYCHOPHARMACOL, V1, P179 CARR DB, 2000, J NEUROSCI, V20, P3864 CASTREN E, 2004, CURR OPIN PHARMACOL, V4, P58 CHADI G, 1993, NEUROSCI LETT, V160, P171 CHARNEY DS, 1998, J CLIN PSYCHIAT S14, V59, P11 CHAZAL G, 1986, J NEUROCYTOL, V15, P777 CHEN KC, 2002, J NEUROCHEM, V81, P94 CHRISTIE MJ, 1989, J NEUROSCI, V9, P3584 CHRISTIE MJ, 1993, NEUROSCIENCE, V56, P129 CIRUELA F, 2006, J NEUROSCI, V26, P2080 COLOTTA F, 1993, SCIENCE, V261, P472 COYLE JT, 2003, NEURON, V38, P157 CUELLO AC, 1983, FED PROC, V42, P2912 DAHLSTROM A, 1964, ACTA PHYSIOL SCAND S, V232, P1 DAHLSTROM A, 1964, ACTA PHYSL SCAND, V60, P293 DAHLSTROM A, 1965, ACTA PHYSIOL SCAND S, V247, P1 DAHLSTROM A, 1965, LIFE SCI, V4, P1207 DALY J, 1973, BRAIN RES, V49, P476 DALY JW, 1974, RES COMMUN CHEM PATH, V7, P175 DANA C, 1989, J NEUROSCI, V9, P2247 DAVIS TP, 1993, CRIT REV NEUROBIOL, V7, P163 DEFELIPE J, 1992, TRENDS NEUROSCI, V15, P237 DELAMORA MP, 1997, NEUROCHEM RES, V22, P1051 DELARCO A, 2003, J NEUROCHEM, V85, P23 DELARCO A, 2007, J NEURAL TRANSM, V114, P32 DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148 DESCARRIES L, 1975, BRAIN RES, V100, P563 DESCARRIES L, 1977, BRAIN RES, V133, P197 DESCARRIES L, 1991, VOLUME TRANSMISSION, P53 DESCARRIES L, 1996, J COMP NEUROL, V375, P167 DESCARRIES L, 1998, J PHYSIOLOGY-PARIS, V92, P215 DESCARRIES L, 2000, PROG BRAIN RES, V125, P27 DEWIED D, 1982, PHYSIOL REV, V62, P976 DIAZ J, 1995, NEUROSCIENCE, V65, P731 DJAMGOZ MBA, 1992, NEUROCHEM INT, V20, P139 DOURNAUD P, 1998, J NEUROSCI, V18, P1056 DSA C, 2002, BIPOLAR DISORD, V4, P183 DUGGAN AW, 1990, NEUROSCIENCE, V35, P195 DUGGAN AW, 1992, BRAIN RES, V579, P261 DUMAN RS, 1997, ARCH GEN PSYCHIAT, V54, P597 DUMAN RS, 2001, NEUROPSYCHOPHARMACOL, V25, P836 EBLEN F, 1995, J NEUROSCI, V15, P5999 EVERITT BJ, 2005, NAT NEUROSCI, V8, P1481 FARDE L, 1988, ARCH GEN PSYCHIAT, V45, P71 FELTEN DL, 1980, NEUROSCI LETT, V16, P275 FENSTERMACHER J, 1988, ANN NY ACAD SCI, V531, P29 FENSTERMACHER JD, 1974, FLUID ENV BRAIN, P201 FERGUSON SSG, 2003, TRENDS NEUROSCI, V26, P119 FERRE S, 1996, EUR J NEUROSCI, V8, P1545 FISHMAN RA, 1992, CEREBROSPINAL FLUID FLACK B, 1962, J HISTOCHEM CYTOCHEM, V10, P348 FOLLESA P, 1994, EXP NEUROL, V127, P37 FROSSBERG H, 2006, BEHAV BRAIN FUNCT, V2, P40 FUXE K, 1963, ACTA PHYSIOL SCAND, V58, P383 FUXE K, 1964, ACTA PHYSIOL SCAND, V62, P493 FUXE K, 1964, Z ZELLFORSCH, V61, P710 FUXE K, 1965, ACTA PHYSIOL SC S247, V64, P37 FUXE K, 1965, Z ZELLFORSCH, V65, P573 FUXE K, 1966, ACTA PHYSIOL SCAND, V66, P245 FUXE K, 1967, HISTOCHEMISTRY, V11, P161 FUXE K, 1967, J PHARM PHARMACOL, V19, P335 FUXE K, 1967, PSYCHOPHARMACOLOGIA, V11, P439 FUXE K, 1968, HISTOCHEMISTRY, V13, P16 FUXE K, 1970, AMPHETAMINES RELATED, P257 FUXE K, 1970, CONTEMPORARY RESEARC, P275 FUXE K, 1970, INT REV NEUROBIOL, V13, P93 FUXE K, 1970, NEUROLEPTICS, P121 FUXE K, 1970, RES COMMUN CHEM PATH, V1, P627 FUXE K, 1973, J HISTOCHEM CYTOCHEM, V21, P293 FUXE K, 1973, SLEEP PHYSL BIOCH PS, P12 FUXE K, 1974, ADV BIOCHEM PSYCHOPH, V10, P1 FUXE K, 1976, SCHIZOPHRENIA TODAY, P135 FUXE K, 1977, MED BIOL, V55, P148 FUXE K, 1977, NEUROSCI LETT, V6, P339 FUXE K, 1977, SCIENCE, V196, P899 FUXE K, 1978, CLIN OBSTET GYNAECOL, V5, P251 FUXE K, 1979, TRENDS NEUROSCI, V2, P1 FUXE K, 1980, ADV BIOCHEM PSYCHOPH, V22, P37 FUXE K, 1980, EUR J PHARMACOL, V67, P329 FUXE K, 1980, PROGR PSYCHONEUROEND, P47 FUXE K, 1981, ACTA PHYSL SCAND, V113, P567 FUXE K, 1983, J NEURAL TRANSM S18, P165 FUXE K, 1983, NEUROPHARMACOLOGY, V22, P389 FUXE K, 1983, NEUROSCI LETT, V43, P185 FUXE K, 1983, SPECIAL ASPECTS PSYC, P13 FUXE K, 1985, DOPAMINERGIC SYSTEM, P11 FUXE K, 1985, MED RES REV, V5, P441 FUXE K, 1986, PROG BRAIN RES, V66, P341 FUXE K, 1988, ADV EXP MED BIOL, V235, P83 FUXE K, 1988, NEUROSCI LETT, V85, P163 FUXE K, 1988, REGULATORY ROLES OPI, P33 FUXE K, 1991, GALANIN NEW MULTIFUN, P221 FUXE K, 1991, VOLUME TRANSMISSION FUXE K, 1991, VOLUME TRANSMISSION, P1 FUXE K, 1996, J CHEM NEUROANAT, V11, P13 FUXE K, 2003, NEUROLOGY, V61, PS19 FUXE K, 2003, NEUROSCIENCE, V119, P733 FUXE K, 2005, J NEURAL TRANSM, V112, P65 FUXE K, 2006, J NEURAL TRANSM-SUPP, P71 FUXE K, 2006, NEUROTRANSMIITER ERA, P219 FUXE K, 2007, J NEURAL TRANSM, V114, P49 GALLY JA, 1990, P NATL ACAD SCI USA, V87, P3547 GALTER D, 1999, NEUROSCIENCE, V88, P549 GARCIAPEREZ E, 2004, BIOPHYS J 1, V86, P646 GARRIS PA, 1994, J NEUROSCI, V14, P6084 GARTHWAITE J, 1989, EUR J PHARM-MOLEC PH, V172, P413 GEER CP, 1997, J NEURO-ONCOL, V32, P193 GEFFEN LB, 1976, NATURE, V260, P258 GERFEN CR, 1984, NATURE, V311, P461 GERFEN CR, 1993, NIDA RES MONOGRAPH S, V125, P82 GERFEN CR, 2000, TRENDS NEUROSCI S, V23, PS64 GINES S, 2000, P NATL ACAD SCI USA, V97, P8606 GOLDING DW, 1994, BIOESSAYS, V16, P503 GONON FG, 1988, NEUROSCIENCE, V24, P19 GONZALEZ MMC, 2006, SLEEP, V29, P1327 GRACE AA, 1983, NEUROSCIENCE, V10, P333 GRANON S, 2006, ACTA PAEDIATR, V95, P645 GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723 GRAYBIEL AM, 2000, TRENDS NEUROSCI S, V23, PS71 GREITZ D, 1991, NEURORADIOLOGY S, V33, P178 GREITZ D, 1993, ACTA RADIOL S, V386, P1 GREITZ D, 1993, ACTA RADIOL, V34, P321 GREWAL JS, 2001, J BIOL CHEM, V276, P27335 GUILLEMIN R, 1978, SCIENCE, V202, P390 GWINN RP, 2002, NEUROSCIENCE, V114, P403 HACKEL PO, 1999, CURR OPIN CELL BIOL, V11, P184 HAJOS M, 1994, 3 IUPHAR SAT M SER HAMBERGER B, 1965, J HISTOCHEM CYTOCHEM, V13, P147 HANSRA N, 2004, J NEUROSCI, V24, P4082 HASKINS JT, 1981, J NEUROCYTOL, V10, P729 HAYAISHI O, 1991, FASEB J, V5, P2575 HEDLUND PB, 1992, EUR J PHARMACOL, V224, P203 HEDLUND PB, 1994, BRAIN RES, V634, P163 HEDLUND PB, 1996, ANN NY ACAD SCI, V780, P193 HEIMER L, 2000, BRAIN RES REV, V31, P205 HERKENHAM M, 1987, NEUROSCIENCE, V23, P1 HERY F, 1982, BRAIN RES BULL, V8, P123 HILLION J, 2002, J BIOL CHEM, V277, P18091 HOFFMAN BJ, 1998, FRONT NEUROENDOCRIN, V19, P187 HOISTAD M, 2000, EUR J NEUROSCI, V12, P2505 HOISTAD M, 2002, J NEUROCHEM, V81, P80 HOISTAD M, 2004, THESIS KAROLINSKA I, P82 HOISTAD M, 2005, BRAIN RES, V1041, P167 HOMYKIEWICZ O, 1963, WEIN KLIN WOCHENSCHR, V75, P309 HORVATH TL, 1999, J NEUROSCI, V19, P10417 HORVATH TL, 2003, BIOCHEM PHARMACOL, V65, P1917 HOYER D, 2002, PHARMACOL BIOCHEM BE, V71, P533 HUBBARD SR, 2004, NAT REV MOL CELL BIO, V5, P464 HURD YL, 2006, CNS SPECTRUMS, V11, P855 IADECOLA C, 1998, NAT NEUROSCI, V1, P263 ICHIMURA T, 1991, BRAIN RES, V545, P103 ISHIMATSU M, 1996, J NEUROSCI, V16, P5196 IVANOV IS, 2006, CNS SPECTRUMS, V11, P864 IVERSEN L, 2000, MOL PSYCHIATR, V5, P357 JACKSON IMD, 1980, NEUROBIOLOGY CEREBRO, P625 JACOBS BL, 1992, PHYSIOL REV, V72, P165 JACOBSEN KX, 2006, NEUROSCIENCE, V141, P2007 JACOBSON M, 1993, FDN NEUROSCIENCE JAN LY, 1982, J PHYSIOL-LONDON, V327, P219 JAN YN, 1983, PROG BRIAN RES, V58, P49 JANSSON A, 1998, NEUROREPORT, V9, P2505 JANSSON A, 1999, NEUROSCIENCE, V89, P473 JANSSON A, 1999, THESIS KAROLINSKA I, P61 JANSSON A, 2000, PROG BRAIN RES, V125, P399 JANSSON A, 2001, J CHEM NEUROANAT, V22, P185 JANSSON A, 2002, NEURONAL ENV BRAIN H, P83 JANSSON A, UNPUB LOCAL MICROINJ JENTSCH JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201 JONSSON G, 1975, MED BIOL, V53, P25 JOUVET M, 1972, ERGEBN PHYSL, V64, P166 KAMIYA T, 2003, BIOCHEM BIOPH RES CO, V306, P544 KANG HJ, 1995, SCIENCE, V267, P1658 KAPUR S, 2003, PROG NEURO-PSYCHOPH, V27, P1081 KEMPERMANN G, 2003, BIOL PSYCHIAT, V54, P499 KIIANMAA K, 1977, BRAIN RES, V131, P287 KIM JS, 1980, NEUROSCI LETT, V20, P379 KIMELBERG H, 1988, GLIAL CELL RECEPTORS KISER RS, 1983, BRAIN RES, V288, P187 KITAYAMA IT, 2004, ACTA NEUROPSYCHIATR, V16, P190 KOMENDANTOV AO, 2002, J NEUROPHYSIOL, V87, P1526 KOOB G, 1990, DECADE NEUROPEPTIDES KOPELL N, 2004, P NATL ACAD SCI USA, V101, P15482 KOTECHA SA, 2002, NEURON, V35, P1111 KRUEGER JM, 1995, INT ARCH ALLERGY IMM, V106, P97 KUHAR MJ, 1985, NIDA RES MONOGR, V62, P1 LARUELLE M, 1996, P NATL ACAD SCI USA, V93, P9235 LARUELLE M, 2003, ANN NY ACAD SCI, V1003, P138 LAUF U, 2002, P NATL ACAD SCI USA, V99, P10446 LEBIHAN D, 1993, NEUROREPORT, V4, P887 LEE FJS, 2002, CELL, V111, P219 LEE FS, 2001, P NATL ACAD SCI USA, V98, P3555 LEE FS, 2002, CYTOKINE GROWTH F R, V13, P11 LESCH KP, 2001, J AFFECT DISORDERS, V62, P57 LEUNG DSY, 2002, INT J DEV NEUROSCI, V20, P63 LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861 LI XM, 1995, BRAIN RES, V679, P157 LICINIO J, 1997, J CLIN INVEST, V100, P2941 LIDBRINK P, 1973, J PHARM PHARMACOL, V25, P84 LINDVALL O, 1974, ACTA PHYSIOL SCAND, V412, P1 LIPPOLDT A, 2000, BRAIN RES, V854, P197 LIPPOLDT A, 2000, NEUROREPORT, V11, P1427 LIU F, 2000, NATURE, V403, P274 LIU HT, 1994, P NATL ACAD SCI USA, V91, P1009 LIU XY, 2006, NEURON, V52, P897 LOFSTROM A, 1976, J HISTOCHEM CYTOCHEM, V24, P415 LOFSTROM A, 1976, J HISTOCHEM CYTOCHEM, V24, P430 LOWES VL, 2002, NEUROSIGNALS, V11, P5 LUTTRELL LM, 1997, J BIOL CHEM, V272, P4637 LUTTRELL LM, 1999, CURR OPIN CELL BIOL, V11, P177 LUTTRELL LM, 2002, CAN J PHYSIOL PHARM, V80, P375 MACLEOD RM, 1974, ENDOCRINOLOGY, V94, P1077 MACMILLAN SJA, 1998, BRAIN RES, V794, P127 MAEDA T, 1972, BRAIN RES, V36, P19 MALLEI A, 2002, MOL PHARMACOL, V61, P1017 MALMFORS T, 1965, ACTA PHYSIOL SCAND S, V248, P1 MANJI HK, 2001, NAT MED, V7, P541 MANJI HK, 2003, SCI STKE, PE49 MANSOUR A, 1986, BRAIN RES, V399, P69 MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308 MARAGNOLI ME, 2004, BIOL PSYCHIAT, V55, P1095 MARCELLINO D, 2007, BRAIN RES, V1143, P208 MARINISSEN MJ, 2001, TRENDS PHARMACOL SCI, V22, P368 MARTIN DL, 1992, GLIA, V5, P81 MARTIN JH, 1985, PRINCIPLES NEURAL SC, P636 MARTINCORA FJ, 2005, EUR J NEUROSCI, V22, P3195 MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366 MATTSON MP, 2004, TRENDS NEUROSCI, V27, P589 MAYERI E, 1985, J NEUROSCI, V5, P2060 MEYERLINDENBERG A, 2002, NAT NEUROSCI, V5, P267 MIYAN JA, 2003, CAN J PHYSIOL PHARM, V81, P317 MOBLEY P, 1985, P NATL ACAD SCI USA, V82, P945 MOLLGARD K, 1975, ADV NEUROL, V12, P79 MONTAGUE PR, 1996, J NEUROSCI, V16, P1936 MORRIS G, 2004, NEURON, V43, P133 MORRIS M, 1975, NEUROENDOCRINOLOGY, V18, P131 MURASE S, 1993, J NEURAL TRANSM-GEN, V91, P13 MURPHY BL, 2000, ENVIRON FORENSICS, V1, P155 MURPHY S, 1987, NEUROSCIENCE, V22, P381 MURPHY S, 1993, TRENDS NEUROSCI, V16, P323 NAGY JI, 2004, BRAIN RES REV, V47, P191 NEDERGAARD M, 1994, SCIENCE, V263, P1768 NEMEROFF CB, 1998, BIOL PSYCHIAT, V44, P517 NESTLER EJ, 2002, NEURON, V34, P13 NEWMANTANCREDI A, 1997, EUR J PHARMACOL, V319, P379 NIBUYA M, 1995, J NEUROSCI, V15, P7539 NICHOLSON C, 1979, NEUROSCIENCES 4 STUD NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225 NICHOLSON C, 1998, TRENDS NEUROSCI, V21, P207 NICHOLSON C, 1999, TRENDS NEUROSCI, V22, P143 NICHOLSON C, 2001, REP PROG PHYS, V64, P815 NIEUWENHUYS R, 1985, CHEMOARCHITECTURE BR NORDSTROM AL, 1993, BIOL PSYCHIAT, V33, P227 NYGREN LG, 1977, BRAIN RES, V132, P85 OADES RD, 2005, DEVELOPMENTAL SCI, V8, P122 OGREN SO, 1979, J NEURAL TRANSM, V46, P85 OLSON L, 1971, BRAIN RES, V28, P165 OLSON L, 1972, BRAIN RES, V43, P289 OLSON L, 1972, BRAIN RES, V44, P283 ORMOND J, 2004, NEURON, V44, P715 OUIMET CC, 1984, J NEUROSCI, V4, P111 PASQUINI F, 1992, J COMP NEUROL, V326, P229 PATAPOUTIN A, 2001, CURR OPIN NEUROBIOL, V11, P272 PATHAK A, 2003, BRIT J NEUROSURG, V17, P306 PAUTPAGANO L, 1993, NEUROENDOCRINOLOGY, V58, P682 PEREDA AE, 1996, J NEUROSCI, V16, P983 PEREDA AE, 1998, P NATL ACAD SCI USA, V95, P13272 PEROUTKA SJ, 1979, MOL PHARMACOL, V16, P687 PEROUTKA SJ, 1980, J PHARMACOL EXP THER, V215, P582 POST RM, 1982, LIFE SCI, V31, P1 PROESCHOLDT MG, 2000, NEUROSCIENCE, V95, P577 QUARTA D, 2007, NEUROPSYCHOPHARMACOL, V32, P35 RAJAGOPAL R, 2004, J NEUROSCI, V24, P6650 RAJKOWSKA G, 1999, BIOL PSYCHIAT, V45, P1085 RAUCH BH, 2004, CIRC RES, V94, P340 RENNELS ML, 1985, BRAIN RES, V326, P47 RENNELS ML, 1990, ADV NEUROL, V52, P431 RIAD M, 2000, J COMP NEUROL, V417, P181 RICE ME, 2000, VOLUME TRANSMISSIO R, V125, P277 RIDET JL, 1992, BRAIN RES, V598, P233 RIVERA A, 2002, J NEUROCHEM, V80, P219 RIVERA A, 2006, NEUROSCIENCE, V137, P1447 ROBINSON TE, 1993, BRAIN RES REV, V18, P247 ROCHEVILLE M, 2000, SCIENCE, V288, P154 RORIG B, 1996, EUR J NEUROSCI, V8, P1685 ROUTTENBERG A, 1968, SCIENCE, V161, P272 RUSAKOV DA, 1998, TRENDS NEUROSCI, V21, P469 RUSAKOV DA, 1999, TRENDS NEUROSCI, V22, P382 SAARELAINEN T, 2003, J NEUROSCI, V23, P349 SALAMONE JD, 1997, NEUROSCI BIOBEHAV R, V21, P341 SANTARELLI L, 2003, SCIENCE, V301, P805 SCHAIBLE HG, 1992, EUR J NEUROSCI, V4, P750 SCHLOSS P, 2004, PHARMACOL THERAPEUT, V102, P47 SCHMITT FO, 1984, NEUROSCIENCE, V13, P991 SCHMITZ D, 2001, NEURON, V31, P831 SCHOBITZ B, 1994, PROG NEUROBIOL, V44, P397 SCHULTZ W, 2002, NEURON, V36, P241 SCHWARTZ JC, 1998, BRAIN RES REV, V26, P236 SEEMAN P, 1975, P NATL ACAD SCI USA, V72, P4376 SEGAL MB, 2000, CELL MOL NEUROBIOL, V20, P183 SESACK SR, 1994, J NEUROSCI, V14, P88 SHAH BH, 2004, TRENDS NEUROSCI, V27, P48 SHEPHERD G, 1991, FDN NEURON DOCTRINE SHEPHERD G, 1994, NEUROBIOLOGY SHERRINGTON C, 1947, FG INTEGRATIVE ACTIO SHIPLEY MT, 1996, J COMP NEUROL, V365, P56 SHIRAYAMA Y, 2002, J NEUROSCI, V22, P3251 SILVER R, 1996, NATURE, V382, P810 SKINNER DC, 1999, ENDOCRINOLOGY, V140, P4399 SKIRBOLL LR, 1979, SCIENCE, V206, P80 SKOLNICK P, 1999, EUR J PHARMACOL, V375, P31 SNYDER SH, 1991, TRENDS PHARMACOL SCI, V12, P125 SOHL G, 2005, NAT REV NEUROSCI, V6, P191 SONTHEIMER H, 1988, GLIA, V1, P328 SOSSIN WS, 1989, NEURON, V2, P1407 STEINBUSCH HWM, 1978, NEUROSCIENCE, V3, P811 STEINBUSCH HWM, 1981, ADV EXP MED BIOL, V133, P7 STEINBUSCH HWM, 1981, J PHYSIOL-PARIS, V77, P157 STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557 STEZHKA VV, 1995, EXP BRAIN RES, V105, P383 STONE EA, 1989, BRAIN RES REV, V14, P297 STROMBERG I, 2000, PROG BRAIN RES, V125, P309 SVENSSON TH, 2000, BRAIN RES REV, V31, P320 SYKOVA E, 1998, EXP GERONTOL, V33, P837 SYKOVA E, 2004, NEUROCHEM INT, V45, P453 TAKASE LF, 2004, BEHAV BRAIN RES, V153, P233 TAMAS G, 2000, NAT NEUROSCI, V3, P366 TAYLOR C, 2005, CELL SIGNAL, V17, P549 TENNYSON VM, 1972, BRAIN RES, V46, P251 THURESONKLEIN AK, 1990, INT REV CYTOL, V121, P67 TORVINEN M, 2005, MOL PHARMACOL, V67, P400 TRAVAGLI RA, 1995, J NEUROPHYSIOL, V74, P518 TURNER CA, 2006, BIOL PSYCHIAT, V59, P1128 UMBRIACO D, 1994, J COMP NEUROL, V348, P351 UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107 UNGERSTEDT U, 1969, BRAIN RES, V14, P461 UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND S, V367, P1 UNGLESS MA, 2004, TRENDS NEUROSCI, V27, P702 URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070 USHER M, 1999, SCIENCE, V283, P549 VANDECASTEELE M, 2005, J NEUROSCI, V25, P291 VANHARREVELD A, 1972, STRUCTURE FUNCTION N, P447 VINCENT B, 1996, J NEUROSCI, V16, P5049 VIZI E, 1984, NONSYNAPTIC INTERACT VORISEK I, 1997, J NEUROPHYSIOL, V78, P912 WANG R, 2002, FASEB J, V16, P1792 WANG RY, 1982, J NEUROSCI, V2, P11 WANG Y, 1996, LIFE SCI, V59, P1783 WESTERINK BHC, 2001, J NEUROSCI METH, V109, P53 WIESEL FA, 1978, BRAIN RES, V148, P399 WITKOVSKY P, 1993, P NATL ACAD SCI USA, V90, P5667 YABLONSKIY DA, 2000, P NATL ACAD SCI USA, V97, P7603 YUNG KKL, 1995, NEUROSCIENCE, V65, P709 ZHANG ET, 1992, ACTA NEUROPATHOL, V83, P233 ZHU PC, 1986, NEUROSCIENCE, V19, P43 ZIGMOND MJ, 2000, PROG BRAIN RES, V125, P317 ZOLI M, 1989, ACTA PHYSIOL SCAND, V135, P201 ZOLI M, 1996, PROG NEUROBIOL, V49, P363 |